Average Co-Inventor Count = 12.59
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (19 from 169 patents)
2. Celgene Corporation (5 from 549 patents)
3. Biotheryx, Inc. (1 from 36 patents)
25 patents:
1. 12419962 - Quinazolines, pharmaceutical compositions, and therapeutic applications
2. 12404241 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
3. 11919879 - Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases
4. 11873283 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
5. 11325889 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
6. 11292796 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
7. 11149007 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
8. 10683298 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
9. 10167290 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
10. 9783505 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
11. 9771371 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
12. 9556126 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
13. 9193692 - Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
14. 9156798 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
15. 9079900 - Methods of synthesis and purification of heteroaryl compounds